High induction rate onto extended-release naltrexone for people with opioid use disorder: experiences from a Norwegian naturalistic study

Abstract Background For people with opioid use disorder (OUD), extended-release naltrexone (XR-NTX) is an effective antagonist treatment option. However, successful opioid tapering and abstinence is a prerequisite for XR-NTX induction and has repeatedly been reported as a major barrier to effective...

Полное описание

Библиографические подробности

Главные авторы:	Jon Mordal, Farid Juya, Line Holtan, John-Kåre Vederhus, Arild Opheim, Ida H. Brenna, Asle E. Enger, Bente Weimand, Kristin Klemmetsby Solli, Lars Tanum
Формат:	Artigo
Язык:	Inglês
Опубликовано:	BMC 2025-06-01
Серии:	Addiction Science & Clinical Practice
Предметы:	Opioid use disorder Extended-release naltrexone Medically managed withdrawal Treatment induction
Online-ссылка:	https://doi.org/10.1186/s13722-025-00576-9
Метки:	Добавить метку Нет меток, Требуется 1-ая метка записи!